This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Adults with type 2 diabetes using metformin had a slightly lower risk of dying or developing long COVID within 180 days after SARS-CoV-2 infection than those using other diabetes medications.
Medscape Medical News